Sheffali Gulati, MD
All India Institute of Medical Sciences
9
7
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Suvasini Sharma, MD
All India Institute of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Suvasini Sharma, MD, DM
All India Institute of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Anuja Agarwala, MSc
All India Institute of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Liankun Ren, MD
Xuanwu Hospital, Beijing
Shared therapeutic areas:
Alexander Kolevzon, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Esmael M Ahmed, MD
Assistant Prof of Neurology
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
Comparison of Efficacy of LGIT and MAD Among Children With Drug Resistant Epilepsy
Modified Atkins Diet in Childhood Epilepsy
Use of the Modified Atkins Diet in Infantile Spasms
Low Glycemic Index Diet Therapy in Children With Refractory Epilepsy
Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT
Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years
Development and Validation of a Comprehensive Module for Management of Sleep Disorders in ASD Children
Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD
All 9 trials loaded